Indoco Remedies declined 2.54% to Rs 255.40 after the U.S. Food and Drug Administration (USFDA) had inspected the company’s manufacturing facility at Plant II (Sterile) located at Goa
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.